Elekta

The company’s development will be presented by Elekta’s President and CEO, Gustaf Salford, together with CFO, Tobias Hägglöv. After the presentation, held in English, a Q&A session will follow.
 
The presentation will be broadcast live on the web. It will be necessary to join the phone conference if you plan to ask questions. A recording of the webcast can be found on Elekta’s website after the call.
 
Welcome!
 
Time: Wednesday, November 27, at 10:00 a.m. CET

Telephone numbers to join phone conference:
UK: +44 (0) 207 107 06 13
USA: +1 (1) 631 570 56 13
Sweden: +46 (0) 8 5051 0031

Webcast: https://bit.ly/3Ag9rXu

# # #

For further information, please contact:
Peter Nyquist, Head of Investor Relations
Tel: +46 70 575 2906, e-mail: peter.nyquist@elekta.com
Time zone: CET (Central European Time)

About Elekta
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 40 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on Twitter.